ARS-1630
CAS No. 1698055-86-5
ARS-1630( ARS1630 | ARS1620 R-atropisomer )
Catalog No. M12592 CAS No. 1698055-86-5
ARS-1630 is the R-conformational atropisomer of ARS-1620.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 90 | In Stock |
|
| 5MG | 79 | In Stock |
|
| 10MG | 115 | In Stock |
|
| 25MG | 228 | In Stock |
|
| 50MG | 321 | In Stock |
|
| 100MG | 421 | In Stock |
|
| 200MG | 600 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameARS-1630
-
NoteResearch use only, not for human use.
-
Brief DescriptionARS-1630 is the R-conformational atropisomer of ARS-1620.
-
DescriptionARS-1630 is the R-conformational atropisomer of ARS-1620, 1,000-fold less potent than ARS-1620 (1.2 ± 0.6 M-1s-1) and thus acts as a unique inactive control compound.
-
In VitroKRASG12C is recently identified to be potentially druggable by allele-specific covalent targeting of Cys-12 in vicinity to an inducible allosteric switch II pocket (S-IIP). Success of this approach requires active cycling of KRASG12C between its active-GTP and inactive-GDP conformations as accessibility of the S-IIP is restricted only to the GDP-bound state. This strategy proves feasible for inhibiting mutant KRAS in vitro.
-
In Vivo——
-
SynonymsARS1630 | ARS1620 R-atropisomer
-
PathwayMAPK/ERK Signaling
-
TargetRas
-
RecptorRas
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1698055-86-5
-
Formula Weight430.84
-
Molecular FormulaC21H17ClF2N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 69 mg/mL 160.15 mM
-
SMILESC=CC(N1CCN(C2=C3C=C(Cl)[C@@]([C@@]4=C(O)C=CC=C4F)=C(F)C3=NC=N2)CC1)=O.[R]
-
Chemical Name(R)-1-(4-(6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Janes MR, et al. Cell. 2018 Jan 25;172(3):578-589.e17.
molnova catalog
related products
-
PDEδ-IN-99
PDEδ-IN-99 is a novel potent K-Ras-PDEδ inhibitor that binds to the farnesyl binding pocket of PDEδ with Kd of 8±4 nM.
-
CMC2.24
CMC2.24 (TRB-N0224) is a novel tricarbonylmethane agent that inhibits the Ras-RAF-MEK-ERK pathway.
-
KRAS4b-PDEδ stablize...
KRAS4b-PDEδ stablizer C19 is a small molecule that binds and stablizes the KRAS4b-PDEδ complex.
Cart
sales@molnova.com